Ariana Boswell

All articles by Ariana Boswell

• 2026 Muscular Dystrophy Association conference highlights recent advancements

  Researchers highlighted recent advances in DMD research at the Muscular Dystrophy Association’s Clinical & Scientific Conference.

• How to ‘Light Up for Rare’ on Rare Disease Day

  Landmarks worldwide will light up on Rare Disease Day.

• (Z)-Endoxifen receives Rare Pediatric Disease designation from FDA

  (Z)-Endoxifen, a drug being developed by Atossa Therapeutics for DMD, recently received Rare Pediatric Disease Designation from the FDA.

• Deramiocel trial yields positive results in patients with DMD

  Findings from the HOPE-3 trial indicate that deramiocel may improve cardiac and skeletal muscle health in patients with DMD.

• Obestatin alleviates symptoms and improves muscle health in DMD models

  In mouse and human cell models of DMD, treatment with obestatin repaired muscle damage and improved cellular function.

• Can adults with DMD live independently?

  For individuals with DMD, “living on your own” can take on many different meanings.

• Regular use of lung volume recruitment therapy low in DMD

  Fewer than half of participants with DMD who were prescribed LVR therapy adhered to their treatment protocol, a study found.

• Trehalose may improve effects of microdystrophin therapy in DMD

  Researchers found that trehalose further improved cellular function in animal models of DMD treated with microdystrophin therapy.

• Synthetic molecule prevents DMD in mouse model

  A study found that a synthetic compound known as a BB polymer may protect skeletal and cardiac muscles from damage in DMD.

• Experimental drug improves gut-muscle crosstalk in DMD mice

  Researchers found that targeting gut microbiome dysfunction in a mouse model of DMD improves muscle health and function.